| Literature DB >> 34630394 |
Jeremy L Everson1, Darbi R Jones2, Amy K Taylor2, Barb J Rutan2, Timothy D Leeds1, Kate E Langwig3, Andrew R Wargo2, Gregory D Wiens1.
Abstract
Infectious hematopoietic necrosis virus (IHNV) and Flavobacterium psychrophilum are major pathogens of farmed rainbow trout. Improved control strategies are desired but the influence of on-farm environmental factors that lead to disease outbreaks remain poorly understood. Water reuse is an important environmental factor affecting disease. Prior studies have established a replicated outdoor-tank system capable of varying the exposure to reuse water by controlling water flow from commercial trout production raceways. The goal of this research was to evaluate the effect of constant or pulsed reuse water exposure on survival, pathogen prevalence, and pathogen load. Herein, we compared two commercial lines of rainbow trout, Clear Springs Food (CSF) and Troutex (Tx) that were either vaccinated against IHNV with a DNA vaccine or sham vaccinated. Over a 27-day experimental period in constant reuse water, all fish from both lines and treatments, died while mortality in control fish in spring water was <1%. Water reuse exposure, genetic line, vaccination, and the interaction between genetic line and water exposure affected survival (P<0.05). Compared to all other water sources, fish exposed to constant reuse water had 46- to 710-fold greater risk of death (P<0.0001). Tx fish had a 2.7-fold greater risk of death compared to CSF fish in constant reuse water (P ≤ 0.001), while risk of death did not differ in spring water (P=0.98). Sham-vaccinated fish had 2.1-fold greater risk of death compared to vaccinated fish (P=0.02). Both IHNV prevalence and load were lower in vaccinated fish compared to sham-vaccinated fish, and unexpectedly, F. psychrophilum load associated with fin/gill tissues from live-sampled fish was lower in vaccinated fish compared to sham-vaccinated fish. As a result, up to forty-five percent of unvaccinated fish were naturally co-infected with F. psychrophilum and IHNV and the coinfected fish exhibited the highest IHNV loads. Under laboratory challenge conditions, co-infection with F. psychrophilum and IHNV overwhelmed IHNV vaccine-induced protection. In summary, we demonstrate that exposure to reuse water or multi-pathogen challenge can initiate complex disease dynamics that can overwhelm both vaccination and host genetic resistance.Entities:
Keywords: DNA vaccination; Flavobacterium psychrophilum; aquaculture; genetic resistance; infectious hematopoietic necrosis virus; natural exposure; rainbow trout; reuse water
Mesh:
Substances:
Year: 2021 PMID: 34630394 PMCID: PMC8493035 DOI: 10.3389/fimmu.2021.721048
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561
Figure 1Experimental design and water quality measurements. (A) Schematic diagram of water flow to production raceway series 2, 3 and 4 and the collection of first and fourth use water for outdoor tank system. The reuse water has passed through three raceways (3 uses) and was equally comingled prior to supplying the outdoor experimental tank systems, constituting the reuse (4th use) treatment. Water exposure groups (B), temperature (C) and oxygen profiles (D). Spring water (squares) Reuse water (circles).
Mortality, sampling, and survival proportion of fish in 28-day field experiment (including day -1).
| Water Exposure | Genetic line | Treatment | TotalFish | Deaths | Live Sampled(day 1-26)(Censored) | Alive(day 27) | SurvivalProportions(%) | MedianSurvival (days) | Live sampled |
|---|---|---|---|---|---|---|---|---|---|
| Control | CSF | Shm | 97 | 0 | 51 | 46 | 100.0 | ND | 1,3,6,10,12,17,19,24,26,27 |
| Vacc | 99 | 0 | 51 | 48 | 100.0 | ND | 1,3,6,10,12,17,19,24,26,27 | ||
| Tx | Shm | 100 | 0 | 51 | 49 | 100.0 | ND | 1,3,6,10,12,17,19,24,26,27 | |
| Vacc | 100 | 1 | 51 | 48 | 98.6 | ND | 1,3,6,10,12,17,19,24,26,27 | ||
| Constant | CSF | Shm | 99 | 67 | 32 | 0 | 0.0 | 11 | 1,3,6,10,12,24 |
| Vacc | 97 | 61 | 36 | 0 | 0.0 | 17 | 1,3,6,10,12,19 | ||
| Tx | Shm | 100 | 69 | 31 | 0 | 0.0 | 9 | 1,3,6,10,12 | |
| Vacc | 98 | 67 | 31 | 0 | 0.0 | 9 | 1,3,6,10,12 | ||
| Donor | CSF | Shm | 99 | 67 | 32 | 0 | 0.0 | 16 | 1,3,6,10,12,24 |
| Vacc | 98 | 67 | 31 | 0 | 0.0 | 12 | 1,3,6,10,12 | ||
| Tx | Shm | 99 | 68 | 31 | 0 | 0.0 | 9 | 1,3,6,10,12 | |
| Vacc | 100 | 69 | 31 | 0 | 0.0 | 10 | 1,3,6,10,12 | ||
| Pulsed | CSF | Shm | 98 | 4 | 51 | 43 | 93.5 | ND | 1,3,6,10,12,17,19,24,26,27 |
| Vacc | 100 | 0 | 51 | 49 | 100.0 | ND | 1,3,6,10,12,17,19,24,26,27 | ||
| Tx | Shm | 100 | 21 | 51 | 28 | 67.5 | ND | 1,3,6,10,12,17,19,24,26,27 | |
| Vacc | 96 | 7 | 51 | 38 | 88.8 | ND | 1,3,6,10,12,17,19,24,26,27 | ||
| Recipient | CSF | Shm | 100 | 6 | 51 | 43 | 89.8 | ND | 1,3,6,10,12,17,19,24,26,27 |
| Vacc | 100 | 5 | 51 | 44 | 90.6 | ND | 1,3,6,10,12,17,19,24,26,27 | ||
| Tx | Shm | 101 | 14 | 51 | 36 | 80.4 | ND | 1,3,6,10,12,17,19,24,26,27 | |
| Vacc | 94 | 1 | 51 | 42 | 97.9 | ND | 1,3,6,10,12,17,19,24,26,27 |
Survival fractions were calculated using the product limit (Kaplan-Meier) method (GraphPad Prism 7.04).
Seven fish were sampled on days 1, 3, and 6, while 5 or fewer were sampled at remaining time points. ND, Not Determined.
Figure 2Survival of two genetic lines of rainbow trout exposed to various water reuse paradigms and IHNV vaccination. Plots show proportion of fish surviving different water treatments. Overall comparison of water treatments in which genetic line and vaccine treatments were collapsed (A), Constant reuse water exposed group comparing genetic line and treatment (B). Note the Constant and Donor groups were combined by genetic line and vaccine status. Pulsed reuse water exposed group comparing genetic line and vaccine treatment (C), and Recipient group comparing genetic line and vaccine treatment (D).
Significant effects survival analysis in the field experiment.
| Effect | DF | Wald Chi-Square | Pr>ChiSq |
|---|---|---|---|
| Water Reuse | 3 | 447.7393 |
|
| Genetic Line | 1 | 4.2012 |
|
| Vaccination | 1 | 5.2601 |
|
| Line*Water | 3 | 8.2047 |
|
| Water*Vaccination | 3 | 7.7262 | 0.052 |
| Line*Vaccination | 1 | 0.8484 | 0.357 |
| Line*Water*Vaccination | 3 | 3.7954 | 0.2844 |
DF, degrees of freedom.
Pr>ChiSq, probability that the Chi-Square test statistic is greater than or equal to what has been observed under the null hypothesis.
*indicates interaction between or among effects. Bold values P < 0.05.
Model contrasts, hazard ratio and P-value for survival analysis comparisons from field experiment.
| Factor | Contrast | Hazard Ratio | StdErr | lower 95% CI | upper 95% CI | WaldChiSq | DF | Pr>ChiSq |
|---|---|---|---|---|---|---|---|---|
| Water | Constant | 422.400 | 216.200 | 154.900 | 1152.100 | 139.518 | 1 |
|
| Constant | 77.286 | 24.569 | 41.448 | 144.100 | 187.021 | 1 |
| |
| Constant | 87.219 | 27.746 | 46.755 | 162.700 | 197.301 | 1 |
| |
| Pulse | 5.466 | 3.188 | 1.743 | 17.141 | 8.484 | 1 |
| |
| Recip | 4.844 | 2.824 | 1.545 | 15.185 | 7.323 | 1 |
| |
| Pulse | 1.129 | 0.479 | 0.491 | 2.592 | 0.081 | 1 | 0.7756 | |
| Line | Tx | 1.962 | 0.645 | 1.030 | 3.736 | 4.201 | 1 |
|
| Vaccination | Sham | 2.125 | 0.698 | 1.116 | 4.045 | 5.260 | 1 |
|
| Line*Water | CSF: Constant | 251.500 | 180.000 | 61.820 | 1022.900 | 59.614 | 1 |
|
| CSF: Constant | 125.400 | 71.450 | 41.029 | 383.100 | 71.866 | 1 |
| |
| CSF: Constant | 45.980 | 14.811 | 24.456 | 86.448 | 141.241 | 1 |
| |
| CSF: Recip | 5.469 | 4.207 | 1.211 | 24.698 | 4.879 | 1 |
| |
| CSF: Pulse | 2.006 | 1.808 | 0.343 | 11.737 | 0.596 | 1 | 0.4400 | |
| CSF: Pulse | 0.367 | 0.233 | 0.106 | 1.275 | 2.490 | 1 | 0.1146 | |
| Tx: Constant | 709.700 | 509.800 | 173.600 | 2900.800 | 83.517 | 1 |
| |
| Tx: Constant | 47.643 | 11.850 | 29.261 | 77.572 | 241.330 | 1 |
| |
| Tx: Constant | 165.400 | 87.989 | 58.337 | 469.200 | 92.267 | 1 |
| |
| Tx: Recip | 4.290 | 3.759 | 0.770 | 23.895 | 2.761 | 1 | 0.0966 | |
| Tx: Pulse | 14.896 | 11.024 | 3.492 | 63.535 | 13.320 | 1 |
| |
| Tx: Pulse | 3.473 | 1.951 | 1.155 | 10.442 | 4.912 | 1 |
| |
| Control: CSF | 1.026 | 1.026 | 0.145 | 7.287 | 0.001 | 1 | 0.9792 | |
| Constant: Tx | 2.749 | 0.261 | 2.283 | 3.311 | 113.803 | 1 |
| |
| Pulse: Tx | 7.235 | 4.342 | 2.231 | 23.459 | 10.872 | 1 |
| |
| Recip: CSF | 1.309 | 0.785 | 0.404 | 4.239 | 0.201 | 1 | 0.6536 |
DF, degrees of freedom.
Pr>ChiSq, probability that the Chi-Square test statistic is greater than or equal to what has been observed under the null hypothesis.
*indicates interaction between factors. Bold values P < 0.05.
Frequency of fish positive for F. psychrophilum, IHNV, or co-infected with both pathogens, that had been removed from tanks alive, euthanized and sampled, or sampled after death in constant reuse water.
| Sampled | Line | Vac | Sampling(days) |
| IHNV+ | Co-infected (Ext or Int) % (n) | ||
|---|---|---|---|---|---|---|---|---|
| External | Internal | External | Internal | |||||
| % (n) | % (n) | % (n) | % (n) | |||||
| Live | CSF | Shm | 10,12 | 60% (12/20) | 5% (1/20) | 10% (2/20) | 10% (2/20) | 10% (2/20) |
| Vac | 10,12 | 80% (16/20) | 5% (1/20) | 5% (1/20) | 0% (0/20) | 0% (0/20) | ||
| Tx | Shm | 10,12 | 55% (11/20) | 25% (5/20) | 60% (12/20) | 45% (9/20) | 40% (8/20) | |
| Vac | 10,12 | 55% (11/20) | 5% (1/20) | 0% (0/20) | 0% (0/20) | 0% (0/20) | ||
| Live Total | 62% (50/80) | 10% (8/80) | 19% (15/80) | 14%(11/80) | 10% (10/80) | |||
| Dead | CSF | Shm | 8,9,18,19 | 27% (4/15) | 14% (2/14) | 7% (1/15) | 7% (1/15) | 7% (1/15) |
| Vac | 8,9,18,19 | 20% (3/15) | 7% (1/15) | 0% (0/15) | 0% (0/15) | 0% (0/15) | ||
| Tx | Shm | 8,9,10 | 36% (4/11) | 10% (1/10) | 18% (2/11) | 20% (2/10) | 18% (2/11) | |
| Vac | 8,9,10,16 | 46% (6/13) | 0% (0/13) | 0% (0/13) | 8% (1/13) | 8% (1/13) | ||
| Dead Total | 31% (17/54) | 8% (4/52) | 6% (3/54) | 8% (4/53) | 7% (4/54) | |||
Data from the Constant and Donor groups were combined.
Figure 3Comparison of pathogen prevalence and load from live and dead-sampled fish held in constant reuse water. Plots compare F. psychrophilum (A) and IHNV (B) prevalence and load (A); Log10(bacterial DNA copies/g tissue); (B) Log10 [viral RNA copies/g tissue or DNA copies)] for mortalities (died between days 8-19) and live-sampled fish (days 10 and 12) reared under constant reuse water (Donor and Constant groups combined). External pathogen was measured in gill/fin-clip homogenates while internal pathogen load was measured in kidney/spleen homogenates. Individual fish loads are indicated in addition to geometric mean. Limit of quantification for both qPCR assays is indicated by dotted line. Numbers indicate positive fish and total sampled for each group. The full datasets for live-sampled and dead-sampled fish are in and , respectively.
Figure 4Effect of IHNV vaccination on external F. psychrophilum load. Plots compare F. psychrophilum prevalence and load (Log10 bacterial DNA copies/g tissue) in gill/fin samples from vaccinated and sham live-sampled fish (A): days 10 and 12) and mortalities (B): died between days 8-19) and reared under constant reuse water (Donor and Constant groups combined). Geometric mean indicated by bar and the limit of the F. psychrophilum qPCR assay indicated by dotted line. P-values denote significant differences between groups. Numbers indicate fish positive and total sampled for each group.
Figure 5Kinetics of internal pathogen load in field studies. Plots show IHNV (A) and F. psychrophilum (B) load [A; Log10 (bacterial DNA copies/g tissue); B: Log10 (viral RNA copies/g tissue or DNA copies)] as well as pathogen prevalence (2nd y-axis, shaded area) in live-sampled, sham-vaccinated Tx-line recipient treatment group fish. Individual co-infected fish are indicated by solid symbols while singly infected fish are indicated by open symbols. N=5 fish per time point. Fish with no pathogen detected are not shown.
Figure 6Fish survival laboratory studies. Plots show survival of two rainbow trout genetic lines, CSF (A, B) and Tx (C, D) that had either been sham vaccinated (A, C) or DNA vaccinated against IHNV (B, D). Fish were challenged with IHNV (dotted line), F. psychrophilum (stippled line) or both pathogens at a 1:1 ratio (solid line).
Significant effects survival analysis in the laboratory experiment.
| Effect | DF | Wald Chi-Square | Pr>ChiSq |
|---|---|---|---|
| Genetic Line | 1 | 0.0639 | 0.8005 |
| Vaccination | 1 | 52.093 |
|
| Line*Vaccination | 1 | 0.3666 | 0.5448 |
| Pathogen | 2 | 208.0453 |
|
| Line*Pathogen | 2 | 1.5114 | 0.4697 |
| Vaccination*Pathogen | 2 | 47.4268 |
|
| Line*Vaccination*Pathogen | 2 | 6.5993 |
|
| Tank | 8.5 | 14.4417 | 0.0879 |
DF, degrees of freedom.
Pr>ChiSq, probability that the Chi-Square test statistic is greater than or equal to what has been observed under the null hypothesis.
Tank effect was removed from final model (NS, and was not a design variable).
*indicates interaction between or among effects.
Model contrasts, hazard ratio and P-value for comparisons from laboratory experiment.
| Factor | Contrast | Hazard Ratio | StdErr | lower 95% CI | upper 95% CI | WaldChiSq | DF | Pr>ChiSq |
|---|---|---|---|---|---|---|---|---|
| Line*Vacc*Path | ||||||||
| Fp: CSF sham | 1.325 | 0.300 | 0.850 | 2.065 | 1.541 | 1 | 0.2145 | |
| Fp: CSF vacc | 1.523 | 0.349 | 0.972 | 2.385 | 3.370 | 1 | 0.0664 | |
| IHNV: Tx sham | 1.154 | 0.309 | 0.682 | 1.952 | 0.286 | 1 | 0.593 | |
| IHNV: Tx vacc | 2.041 | 2.499 | 0.185 | 22.495 | 0.339 | 1 | 0.5602 | |
| Both Path: Tx sham | 1.453 | 0.343 | 0.915 | 2.309 | 2.503 | 1 | 0.1137 | |
| Both Path: CSF vacc | 2.378 | 0.541 | 1.522 | 3.714 | 14.485 | 1 |
| |
| CSF: both sham | 5.009 | 1.172 | 3.167 | 7.923 | 47.446 | 1 |
| |
| CSF: both sham | 16.109 | 4.204 | 9.658 | 26.867 | 113.406 | 1 |
| |
| CSF: Fp sham | 3.216 | 0.825 | 1.945 | 5.318 | 20.713 | 1 |
| |
| Tx: both sham | 9.644 | 2.403 | 5.918 | 15.715 | 82.740 | 1 |
| |
| Tx: both sham | 20.285 | 5.484 | 11.941 | 34.459 | 123.941 | 1 |
| |
| Tx: Fp sham | 2.103 | 0.512 | 1.306 | 3.388 | 9.349 | 1 |
| |
| CSF: Fp vacc | 1.001 | 0.231 | 0.637 | 1.572 | 0.000 | 1 | 0.9963 | |
| CSF: IHNV sham | 41.832 | 42.628 | 5.677 | 308.300 | 13.424 | 1 |
| |
| CSF: both sham | 2.008 | 0.464 | 1.277 | 3.158 | 9.111 | 1 |
| |
| Tx: Fp sham | 1.148 | 0.258 | 0.740 | 1.782 | 0.379 | 1 | 0.5382 | |
| Tx: IHNV sham | 23.656 | 17.287 | 5.649 | 99.072 | 18.744 | 1 |
| |
| Tx: both sham | 6.938 | 1.714 | 4.275 | 11.258 | 61.500 | 1 |
| |
| CSF: both vacc | 335.600 | 340.900 | 45.821 | 2457.900 | 32.773 | 1 |
| |
| Tx: both vacc | 69.170 | 50.311 | 16.626 | 287.800 | 33.926 | 1 |
|
DF, degrees of freedom.
Pr>ChiSq, probability that the Chi-Square test statistic is greater than or equal to what has been observed under the null hypothesis.
*indicates interaction among factors. Bold values P < 0.05.